Evidence map›Paper›PMID 36104122›Full record

Trial reportBMJ open2022

Evaluating the impact of a sleep health education and a personalised smartphone application on sleep, productivity and healthcare utilisation among employees: results of a randomised clinical trial.

Rebecca Robbins, Matthew D Weaver, Stuart F Quan, Jason P Sullivan, Salim Qadri, Laura Glasner, Mairav Cohen-Zion, Charles A Czeisler, Laura K Barger

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04224285 (Operational Trial of Dayzz App), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04224285 nacompletednot on this map

Operational Trial of Dayzz App

TypeinterventionalSponsorBrigham and Women's HospitalRan2020 to 2021Enrolled1,355ConditionsSleep Initiation and Maintenance DisordersArmsDayzz app
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 4 countries.

Rebecca RobbinsDivision of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA rrobbins4@bwh.harvard.edu.ORCID 0000-0003-0288-2505
Matthew D WeaverDivision of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID 0000-0003-3578-336X
Stuart F QuanDivision of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-9474-7679
Jason P SullivanDivision of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-4256-5304
Salim QadriDivision of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID 0000-0003-2972-1197
Laura GlasnerPsychiatric Division, Sheba Medical Center, Tel Hashomer, Israel.
Mairav Cohen-Ziondayzz Live Well Ltd, Herzliya, Israel.ORCID 0000-0001-8603-6466
Charles A CzeislerDivision of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-7408-1849
Laura K BargerDivision of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID 0000-0001-8547-7331
Brigham and Women's Hospital · USSheba Medical Center · IL

Funding

Improving the Health of EMS professionals through Sleep Health Education and Sleep Disorder ScreeningR56HL151637 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WEAVER, MATTHEW DAVID · 2020 to 2020
$793k
An mHealth intervention to deliver personalized messages to increase adherence to OSA evaluation and treatment among transportation workersK01HL150339 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROBBINS, REBECCA · 2020 to 2024
$708k
ACL HHS R01OH011773NHLBI NIH HHS K01 HL150339NHLBI NIH HHS R56 HL151637NIOSH CDC HHS R01 OH011773
6 · The paper itself

Abstract

objectivesWe evaluated an online Sleep Health and Wellness (SHAW) programme paired with dayzz, a personalised sleep training programme deployed via smartphone application (dayzz app) that promotes healthy sleep and treatment for sleep disorders, among employees at a large healthcare organisation.

designOpen-label, randomised, parallel-group controlled trial.

settingA healthcare employer in the USA.

participants1355 daytime workers.

interventionParticipants were randomised to intervention (n=794) or control (n=561) on consent. Intervention participants received the SHAW educational programme at baseline plus access to the personalised dayzz app for up to 9 months. The control condition received the intervention at month 10. PRIMARY AND SECONDARY OUTCOME MEASURES: Our primary outcome measures were sleep-related behavioural changes (eg, consistent sleep schedule); sleep behaviour tracked on an electronic sleep diary and sleep quality. Our secondary outcome measures included employee absenteeism, performance and productivity; stress, mood, alertness and energy; and adverse health and safety outcomes (eg, accidents).

resultsAt follow-up, employees in the intervention condition were more likely to report increased sleep duration on work (7.20 vs 6.99, p=0.01) and on free (8.26 vs 8.04, p=0.03) nights. At follow-up, the prevalence of poor sleep quality was lower in the intervention (n=160 of 321, 50%) compared with control (n=184 of 327, 56%) (p=0.04). The mean total dollars lost per person per month due to reduced workplace performance (presenteeism) was less in the intervention condition (US$1090 vs US$1321, p=0.001). Employees in the intervention reported fewer mental health visits (RR 0.72, 95% CI 0.56 to 0.94, p=0.01) and lower healthcare utilisation over the study interval (RR 0.81, 95% CI 0.67 to 0.98, p=0.03). We did not observe differences in stress (4.7 (95% CI 4.6 to 4.8) vs 4.7 (95% CI 4.6 to 4.8)), mood (4.5 (95% CI 4.4 to 4.6) vs 4.6 (95% CI 4.5 to 4.7)), alertness (4.9 (95% CI 4.8 to 5.0) vs 5.0 (95% CI 4.9 to 5.1)) or adverse health and safety outcomes (motor vehicle crashes: OR 0.82 (95% CI 0.34 to 1.9); near-miss crashes: OR=0.89 (95% CI 0.5 to 1.5) and injuries: 0.9 (95% CI 0.6 to 1.3)); energy was higher at follow-up in the intervention group (4.3 vs 4.5; p=0.03).

conclusionsResults from this trial demonstrate that a SHAW programme followed by access to the digital dayzz app can be beneficial to both the employee and employer. TRIAL REGISTRATION NUMBER: NCT04224285.

Indexed as

Mobile ApplicationsHealth PromotionHumansPatient Acceptance of Health CareSleepSmartphoneInformation technologyOCCUPATIONAL & INDUSTRIAL MEDICINESleep medicine

Identifiers

PMID36104122
PMCPMC9476153
OpenAlexW4295681636

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.